Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 25,766 shares of BSX, which is worth approximately $2.45 Million. The most recent transaction as insider was on Feb 16, 2024, when has been sold 1,355 shares (Common Stock) at a price of $65.82 per share, resulting in proceeds of $89,186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K

9.45% 3M change

55.65% 12M change

Total Value Held $2.45 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 16 2024	SELL Payment of exercise price or tax liability	$89,186 $65.82 p/Share	1,355 Reduced 1.79%	74,219 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	2,970 Added 3.78%	75,574 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$83,492 $65.95 p/Share	1,266 Reduced 1.71%	72,604 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,776 Added 3.62%	73,870 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	12,160 Reduced 14.61%	71,094 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	26,666 Added 24.26%	83,254 Common Stock
Jan 09 2024	SELL Open market or private sale	$898,941 $59.25 p/Share	15,172 Reduced 21.14%	56,588 Common Stock
Jan 09 2024	BUY Exercise of conversion of derivative security	$247,455 $16.31 p/Share	15,172 Added 17.45%	71,760 Common Stock
Jan 04 2024	SELL Open market or private sale	$876,000 $58.4 p/Share	15,000 Reduced 20.95%	56,588 Common Stock
Jan 04 2024	BUY Exercise of conversion of derivative security	$244,649 $16.31 p/Share	15,000 Added 17.32%	71,588 Common Stock
Jan 03 2024	SELL Open market or private sale	$689,850 $57.82 p/Share	11,931 Reduced 17.41%	56,588 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$318,417 $57.81 p/Share	5,508 Reduced 7.44%	68,519 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	17,439 Added 19.07%	74,027 Common Stock
Dec 06 2023	SELL Open market or private sale	$19,425 $55.03 p/Share	353 Reduced 0.62%	56,588 Common Stock
Dec 03 2023	SELL Payment of exercise price or tax liability	$16,617 $56.14 p/Share	296 Reduced 0.52%	56,941 Common Stock
Dec 03 2023	BUY Exercise of conversion of derivative security	-	649 Added 1.12%	57,237 Common Stock
Nov 08 2023	SELL Bona fide gift	-	4,000 Reduced 6.6%	56,588 Common Stock
Aug 29 2023	SELL Open market or private sale	$253,806 $54.5 p/Share	4,657 Reduced 7.14%	60,588 Common Stock
Aug 28 2023	SELL Open market or private sale	$742,418 $53.14 p/Share	13,971 Reduced 17.64%	65,245 Common Stock
Apr 05 2023	SELL Open market or private sale	$247,111 $50.4 p/Share	4,903 Reduced 5.87%	78,673 Common Stock
Mar 30 2023	SELL Open market or private sale	$243,188 $49.6 p/Share	4,903 Reduced 5.54%	83,576 Common Stock
Feb 22 2023	SELL Open market or private sale	$153,974 $46.1 p/Share	3,340 Reduced 3.64%	88,479 Common Stock
Feb 21 2023	SELL Open market or private sale	$107,138 $46.32 p/Share	2,313 Reduced 2.46%	91,819 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$59,128 $46.23 p/Share	1,279 Reduced 1.34%	94,132 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	2,804 Added 2.85%	95,411 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account